OPPORTUNISTIC INFECTIONS caused by the dematiaceous (darkly pigmented) MITOSPORIC FUNGI of ALTERNARIA, Bipolaris, CLADOSPORIUM, Curvularia, and EXOPHIALA. These fungi have pigmented HYPHAE due to MELANIN in the cell wall. The initial subcutaneous cyst from the infection can become systemic and spread rapidly to renal, pulmonary and cerebral systems (see CEREBRAL PHAEOHYPHOMYCOSIS) in an IMMUNOCOMPROMISED HOST.
A normally saprophytic mitosporic Chaetothyriales fungal genus. Infections in humans include PHAEOHYPHOMYCOSIS; and PERITONITIS.. Exophiala jeanselmei (previously Phialophora jeanselmei) is an etiological agent of MYCETOMA.
Superficial infections of the skin or its appendages by any of various fungi.
MYCOSES of the brain, spinal cord, and meninges which may result in ENCEPHALITIS; MENINGITIS, FUNGAL; MYELITIS; BRAIN ABSCESS; and EPIDURAL ABSCESS. Certain types of fungi may produce disease in immunologically normal hosts, while others are classified as opportunistic pathogens, causing illness primarily in immunocompromised individuals (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME).
A mitosporic fungal genus. Phialophora verrucosa is a cause of chromomycosis (CHROMOBLASTOMYCOSIS). Ophiobolus is the teleomorph of Phialophora.
Loose connective tissue lying under the DERMIS, which binds SKIN loosely to subjacent tissues. It may contain a pad of ADIPOCYTES, which vary in number according to the area of the body and vary in size according to the nutritional state.
CNS infections caused by neurotropic dematiaceous fungi that contain melanin in their cell walls. The infections often result in BRAIN ABSCESS; ENCEPHALITIS; and MENINGITIS in patients who are often immunocompetent. The common causative fungi include members Cladophialophora bantiana, Exophiala dermatitidis, Rhinocladiella mackenziei, and Ochroconis gallopavum. R. mackenziei infection is seen almost exclusively in patients from the MIDDLE EAST.
A large and heterogenous group of fungi whose common characteristic is the absence of a sexual state. Many of the pathogenic fungi in humans belong to this group.
Mycoses are a group of diseases caused by fungal pathogens that can infect various tissues and organs, potentially leading to localized or systemic symptoms, depending on the immune status of the host.
A phylum of fungi which have cross-walls or septa in the mycelium. The perfect state is characterized by the formation of a saclike cell (ascus) containing ascospores. Most pathogenic fungi with a known perfect state belong to this phylum.
A nonspecific term used to denote any cutaneous lesion or group of lesions, or eruptions of any type on the leg. (From Stedman, 25th ed)
A genus of ascomycetous fungi of the family Chaetomiaceae, order SORDARIALES. Many members are cellulolytic and some mycotoxic. They occur naturally on paper and cotton fabric.
A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis.
Skin diseases of the foot, general or unspecified.
A circumscribed collection of purulent exudate in the brain, due to bacterial and other infections. The majority are caused by spread of infected material from a focus of suppuration elsewhere in the body, notably the PARANASAL SINUSES, middle ear (see EAR, MIDDLE); HEART (see also ENDOCARDITIS, BACTERIAL), and LUNG. Penetrating CRANIOCEREBRAL TRAUMA and NEUROSURGICAL PROCEDURES may also be associated with this condition. Clinical manifestations include HEADACHE; SEIZURES; focal neurologic deficits; and alterations of consciousness. (Adams et al., Principles of Neurology, 6th ed, pp712-6)
A mitosporic Loculoascomycetes fungal genus including several plant pathogens and at least one species which produces a highly phytotoxic antibiotic. Its teleomorph is Lewia.
Scaly papule or warty growth, caused by five fungi, that spreads as a result of satellite lesions affecting the foot or leg. The extremity may become swollen and, at its distal portion, covered with various nodular, tumorous, verrucous lesions that resemble cauliflower. In rare instances, the disease may begin on the hand or wrist and involve the entire upper extremity. (Arnold, Odom, and James, Andrew's Diseases of the Skin, 8th ed, p362)
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.
A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.
An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.
Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.

Subcutaneous dematiaceous fungal infection. (1/10)

Subcutaneous dematiaceous fungal infections, which include chromoblastomycosis and phaeohyphomycosis, are a heterogeneous group of clinical entities that are caused by dematiaceous or pigmented fungi found in soil. These infections have a wide spectrum of clinical presentations that depend largely on the specific causative organism and on the integrity of the host's immune response. Treatment is challenging and involves a highly individualized plan that often combines both surgical and long-term medical treatment.  (+info)

Intraoral phaeohyphomycosis. (2/10)

 (+info)

Cutaneous phaeohyphomycosis caused by Paraconiothyrium cyclothyrioides. (3/10)

 (+info)

Subcutaneous phaeohyphomycosis caused by Exophiala salmonis. (4/10)

 (+info)

Phaeohyphomycosis: a clinical-epidemiological and diagnostic study of eighteen cases in Rio Grande do Sul, Brazil. (5/10)

 (+info)

Clinical spectrum of exophiala infections and a novel Exophiala species, Exophiala hongkongensis. (6/10)

 (+info)

Phaeohyphomycoses, emerging opportunistic diseases in animals. (7/10)

 (+info)

Pathologic findings in weedy (Phyllopteryx taeniolatus) and leafy (Phycodurus eques) seadragons. (8/10)

 (+info)

Phaeohyphomycosis is a broad term used to describe infections caused by dematiaceous (pigmented) fungi. These fungi have darkly pigmented cell walls containing melanin, which can be seen under the microscope. The infection can involve various tissues in the body, including the skin, nails, hair, lungs, and brain. Symptoms depend on the site of infection and may include skin lesions, lung nodules, or brain abscesses. Diagnosis typically requires identification of the fungus in tissue samples. Treatment usually involves a combination of surgical removal of infected tissue and antifungal medications.

"Exophiala" is a genus of fungi that belongs to the family Herpotrichiellaceae. These fungi are also known as black yeasts because they can form pigmented, thick-walled cells that resemble yeast. They are widely distributed in the environment and have been found in various habitats such as soil, water, and air. Some species of Exophiala are known to cause human diseases, particularly in individuals with weakened immune systems. These infections can affect various organs, including the skin, lungs, and brain. It is important to note that while some species of Exophiala can be pathogenic, many others are not harmful to humans.

Dermatomycoses are a group of fungal infections that affect the skin, hair, and nails. These infections are caused by various types of fungi, including dermatophytes, yeasts, and molds. Dermatophyte infections, also known as tinea, are the most common type of dermatomycoses and can affect different areas of the body, such as the scalp (tinea capitis), beard (tinea barbae), body (tinea corporis), feet (tinea pedis or athlete's foot), hands (tinea manuum), and nails (tinea unguium or onychomycosis). Yeast infections, such as those caused by Candida albicans, can lead to conditions like candidal intertrigo, vulvovaginitis, and balanitis. Mold infections are less common but can cause skin disorders like scalded skin syndrome and phaeohyphomycosis. Dermatomycoses are typically treated with topical or oral antifungal medications.

Central nervous system (CNS) fungal infections refer to invasive fungal diseases that affect the brain and/or spinal cord. These types of infections are relatively uncommon but can be serious and potentially life-threatening, especially in individuals with weakened immune systems due to conditions such as HIV/AIDS, cancer, or organ transplantation.

There are several types of fungi that can cause CNS infections, including:

1. Candida species: These are yeast-like fungi that can cause a range of infections, from superficial to systemic. When they invade the CNS, they can cause meningitis or brain abscesses.
2. Aspergillus species: These are mold-like fungi that can cause invasive aspergillosis, which can affect various organs, including the brain.
3. Cryptococcus neoformans: This is a yeast-like fungus that primarily affects people with weakened immune systems. It can cause meningitis or brain abscesses.
4. Coccidioides species: These are mold-like fungi that can cause coccidioidomycosis, also known as Valley Fever. While most infections are limited to the lungs, some people may develop disseminated disease, which can affect the CNS.
5. Histoplasma capsulatum: This is a mold-like fungus that causes histoplasmosis, which primarily affects the lungs but can disseminate and involve the CNS.

Symptoms of CNS fungal infections may include headache, fever, altered mental status, seizures, stiff neck, and focal neurologic deficits. Diagnosis typically involves a combination of clinical evaluation, imaging studies (such as MRI or CT), and laboratory tests (such as cerebrospinal fluid analysis or fungal cultures). Treatment usually involves long-term antifungal therapy, often with a combination of drugs, and may also include surgical intervention in some cases.

"Phialophora" is a genus of fungi that belongs to the family Herpotrichiellaceae. These fungi are characterized by their pigmented, septate hyphae and the production of flask-shaped conidiogenous cells called phialides. Some species of Phialophora are known to cause various types of infections in humans, particularly in individuals with weakened immune systems. For example, Phialophora verrucosa is a common cause of chromoblastomycosis, a chronic fungal infection that often affects the skin and underlying tissues, leading to the formation of warty or cauliflower-like lesions. Proper diagnosis and treatment of Phialophora infections typically require consultation with a medical professional and may involve the use of antifungal medications.

Subcutaneous tissue, also known as the subcutis or hypodermis, is the layer of fatty connective tissue found beneath the dermis (the inner layer of the skin) and above the muscle fascia. It is composed mainly of adipose tissue, which serves as a energy storage reservoir and provides insulation and cushioning to the body. The subcutaneous tissue also contains blood vessels, nerves, and immune cells that support the skin's functions. This layer varies in thickness depending on the location in the body and can differ significantly between individuals based on factors such as age, genetics, and weight.

Cerebral phaeohyphomycosis is a rare and serious fungal infection that affects the brain. It is caused by darkly pigmented fungi, known as phaeoid or dematiaceous fungi, which contain melanin in their cell walls. These fungi are widely distributed in the environment, particularly in soil, decaying vegetation, and water.

In cerebral phaeohyphomycosis, the fungi invade the brain tissue, causing inflammation, abscess formation, and other neurological symptoms. The infection can occur as a primary disease or secondary to a disseminated systemic infection. People with weakened immune systems, such as those with HIV/AIDS, organ transplants, or hematological malignancies, are at higher risk of developing cerebral phaeohyphomycosis.

The diagnosis of cerebral phaeohyphomycosis is often challenging due to its rarity and nonspecific clinical presentation. Imaging studies such as MRI and CT scans can reveal brain lesions, while microbiological and histopathological examination of biopsied tissue samples can confirm the presence of fungal elements.

Treatment of cerebral phaeohyphomycosis typically involves a combination of surgical resection of the infected brain tissue and systemic antifungal therapy with agents such as amphotericin B, itraconazole, or voriconazole. The prognosis for patients with cerebral phaeohyphomycosis is generally poor, with high rates of morbidity and mortality, especially if the infection is not diagnosed and treated promptly.

Mitosporic fungi, also known as asexual fungi or anamorphic fungi, are a group of fungi that produce mitospores (also called conidia) during their asexual reproduction. Mitospores are produced from the tip of specialized hyphae called conidiophores and are used for dispersal and survival of the fungi in various environments. These fungi do not have a sexual reproductive stage or it has not been observed, making their taxonomic classification challenging. They are commonly found in soil, decaying organic matter, and water, and some of them can cause diseases in humans, animals, and plants. Examples of mitosporic fungi include Aspergillus, Penicillium, and Fusarium species.

Mycoses are a group of diseases caused by fungal infections. These infections can affect various parts of the body, including the skin, nails, hair, lungs, and internal organs. The severity of mycoses can range from superficial, mild infections to systemic, life-threatening conditions, depending on the type of fungus and the immune status of the infected individual. Some common types of mycoses include candidiasis, dermatophytosis, histoplasmosis, coccidioidomycosis, and aspergillosis. Treatment typically involves antifungal medications, which can be topical or systemic, depending on the location and severity of the infection.

Ascomycota is a phylum in the kingdom Fungi, also known as sac fungi. This group includes both unicellular and multicellular organisms, such as yeasts, mold species, and morel mushrooms. Ascomycetes are characterized by their reproductive structures called ascus, which contain typically eight haploid spores produced sexually through a process called ascogony. Some members of this phylum have significant ecological and economic importance, as they can be decomposers, mutualistic symbionts, or plant pathogens causing various diseases. Examples include the baker's yeast Saccharomyces cerevisiae, ergot fungus Claviceps purpurea, and morel mushroom Morchella esculenta.

Leg dermatoses is a general term that refers to various skin conditions affecting the legs. This can include a wide range of inflammatory, infectious, or degenerative diseases that cause symptoms such as redness, itching, scaling, blistering, or pigmentation changes on the leg skin. Examples of specific leg dermatoses include stasis dermatitis, venous eczema, contact dermatitis, lichen planus, psoriasis, and cellulitis among others. Accurate diagnosis usually requires a thorough examination and sometimes a biopsy to determine the specific type of dermatosis and appropriate treatment.

Chaetomium is a genus of saprophytic fungi that are commonly found in soil, decaying plant and animal matter, and dung. The name "Chaetomium" comes from the Greek words "chaete," meaning "long hair," and "tomi," meaning "to cut." This refers to the characteristic long, bristle-like hairs on the ascospores (sexual spores) of these fungi.

Chaetomium species are known for their ability to produce a wide range of enzymes and secondary metabolites, including various pigments, antibiotics, and mycotoxins. Some Chaetomium species have been reported to cause infections in humans, particularly in individuals with weakened immune systems. However, such infections are relatively rare.

In a medical context, the term "Chaetomium" typically refers to the fungal genus as a whole or to specific species within it, rather than to any particular medical definition or condition. If you have any concerns about Chaetomium or other fungi, I would recommend consulting with a healthcare professional or mycologist for further information and advice.

Itraconazole is an antifungal medication used to treat various fungal infections, including blastomycosis, histoplasmosis, aspergillosis, and candidiasis. It works by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes, thereby disrupting the integrity and function of these membranes. Itraconazole is available in oral and intravenous forms for systemic use and as a topical solution or cream for localized fungal infections.

Medical Definition:
Itraconazole (i-tra-KON-a-zole): A synthetic triazole antifungal agent used to treat various fungal infections, such as blastomycosis, histoplasmosis, aspergillosis, and candidiasis. It inhibits the synthesis of ergosterol, a critical component of fungal cell membranes, leading to disruption of their integrity and function. Itraconazole is available in oral (capsule and solution) and intravenous forms for systemic use and as a topical solution or cream for localized fungal infections.

Foot dermatoses refer to various skin conditions that affect the feet. These can include inflammatory conditions like eczema and psoriasis, infectious diseases such as athlete's foot (tinea pedis), fungal infections, bacterial infections, viral infections (like plantar warts caused by HPV), and autoimmune blistering disorders. Additionally, contact dermatitis from irritants or allergens can also affect the feet. Proper diagnosis is essential to determine the best course of treatment for each specific condition.

A brain abscess is a localized collection of pus in the brain that is caused by an infection. It can develop as a result of a bacterial, fungal, or parasitic infection that spreads to the brain from another part of the body or from an infection that starts in the brain itself (such as from a head injury or surgery).

The symptoms of a brain abscess may include headache, fever, confusion, seizures, weakness or numbness on one side of the body, and changes in vision, speech, or behavior. Treatment typically involves antibiotics to treat the infection, as well as surgical drainage of the abscess to relieve pressure on the brain.

It is a serious medical condition that requires prompt diagnosis and treatment to prevent potentially life-threatening complications such as brain herniation or permanent neurological damage.

'Alternaria' is a genus of widely distributed saprophytic fungi that are often found in soil, plant debris, and water. They produce darkly pigmented, septate hyphae and conidia (asexual spores) that are characterized by their distinctive beak-like projections.

Alternaria species can cause various types of plant diseases, including leaf spots, blights, and rots, which can result in significant crop losses. They also produce a variety of mycotoxins, which can have harmful effects on human and animal health.

In humans, Alternaria species can cause allergic reactions, such as hay fever and asthma, as well as skin and respiratory tract infections. Exposure to Alternaria spores is also a known risk factor for the development of allergic bronchopulmonary aspergillosis (ABPA), a condition characterized by inflammation and scarring of the lungs.

It's important to note that medical definitions can vary depending on the context, so it may be helpful to consult a reliable medical or scientific source for more specific information about Alternaria and its potential health effects.

Chromoblastomycosis is a chronic, progressive fungal infection of the skin and underlying tissues. It is caused by several species of dematiaceous (melanin-containing) fungi, which are typically found in soil and organic matter. The disease is most commonly acquired through traumatic inoculation of the fungus into the skin, often through minor cuts, scrapes, or puncture wounds.

The infection initially presents as a painless papule or nodule at the site of inoculation, which may gradually enlarge and become verrucous (wart-like) or cauliflower-like in appearance. The lesions can be single or multiple and are typically found on the lower extremities, particularly the feet and legs. Dissemination to other parts of the body is rare but can occur in immunocompromised individuals.

Chromoblastomycosis is characterized by the formation of muriform (medlar) bodies, which are thick-walled, rectangular, or rounded fungal cells with multiple septations. These structures can be found within giant cells and histiocytes in the dermis and subcutaneous tissues and are considered pathognomonic for the disease.

Diagnosis of chromoblastomycosis is typically made through a combination of clinical presentation, histopathological examination, and fungal culture. Treatment usually involves a combination of surgical excision, physical treatments (such as cryotherapy, thermotherapy, or laser therapy), and antifungal medications (such as itraconazole, posaconazole, or terbinafine). The prognosis for chromoblastomycosis is generally good with early diagnosis and appropriate treatment; however, the infection can become chronic and disfiguring if left untreated or inadequately managed.

Antifungal agents are a type of medication used to treat and prevent fungal infections. These agents work by targeting and disrupting the growth of fungi, which include yeasts, molds, and other types of fungi that can cause illness in humans.

There are several different classes of antifungal agents, including:

1. Azoles: These agents work by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes. Examples of azole antifungals include fluconazole, itraconazole, and voriconazole.
2. Echinocandins: These agents target the fungal cell wall, disrupting its synthesis and leading to fungal cell death. Examples of echinocandins include caspofungin, micafungin, and anidulafungin.
3. Polyenes: These agents bind to ergosterol in the fungal cell membrane, creating pores that lead to fungal cell death. Examples of polyene antifungals include amphotericin B and nystatin.
4. Allylamines: These agents inhibit squalene epoxidase, a key enzyme in ergosterol synthesis. Examples of allylamine antifungals include terbinafine and naftifine.
5. Griseofulvin: This agent disrupts fungal cell division by binding to tubulin, a protein involved in fungal cell mitosis.

Antifungal agents can be administered topically, orally, or intravenously, depending on the severity and location of the infection. It is important to use antifungal agents only as directed by a healthcare professional, as misuse or overuse can lead to resistance and make treatment more difficult.

An immunocompromised host refers to an individual who has a weakened or impaired immune system, making them more susceptible to infections and decreased ability to fight off pathogens. This condition can be congenital (present at birth) or acquired (developed during one's lifetime).

Acquired immunocompromised states may result from various factors such as medical treatments (e.g., chemotherapy, radiation therapy, immunosuppressive drugs), infections (e.g., HIV/AIDS), chronic diseases (e.g., diabetes, malnutrition, liver disease), or aging.

Immunocompromised hosts are at a higher risk for developing severe and life-threatening infections due to their reduced immune response. Therefore, they require special consideration when it comes to prevention, diagnosis, and treatment of infectious diseases.

Opportunistic infections (OIs) are infections that occur more frequently or are more severe in individuals with weakened immune systems, often due to a underlying condition such as HIV/AIDS, cancer, or organ transplantation. These infections are caused by microorganisms that do not normally cause disease in people with healthy immune function, but can take advantage of an opportunity to infect and cause damage when the body's defense mechanisms are compromised. Examples of opportunistic infections include Pneumocystis pneumonia, tuberculosis, candidiasis (thrush), and cytomegalovirus infection. Preventive measures, such as antimicrobial medications and vaccinations, play a crucial role in reducing the risk of opportunistic infections in individuals with weakened immune systems.

A fatal outcome is a term used in medical context to describe a situation where a disease, injury, or illness results in the death of an individual. It is the most severe and unfortunate possible outcome of any medical condition, and is often used as a measure of the severity and prognosis of various diseases and injuries. In clinical trials and research, fatal outcome may be used as an endpoint to evaluate the effectiveness and safety of different treatments or interventions.

Amphotericin B is an antifungal medication used to treat serious and often life-threatening fungal infections. It works by binding to the ergosterol in the fungal cell membrane, creating pores that lead to the loss of essential cell components and ultimately cell death.

The medical definition of Amphotericin B is:

A polyene antifungal agent derived from Streptomyces nodosus, with a broad spectrum of activity against various fungi, including Candida, Aspergillus, Cryptococcus, and Histoplasma capsulatum. Amphotericin B is used to treat systemic fungal infections, such as histoplasmosis, cryptococcosis, candidiasis, and aspergillosis, among others. It may be administered intravenously or topically, depending on the formulation and the site of infection.

Adverse effects associated with Amphotericin B include infusion-related reactions (such as fever, chills, and hypotension), nephrotoxicity, electrolyte imbalances, and anemia. These side effects are often dose-dependent and may be managed through careful monitoring and adjustment of the dosing regimen.

Brain diseases, also known as neurological disorders, refer to a wide range of conditions that affect the brain and nervous system. These diseases can be caused by various factors such as genetics, infections, injuries, degeneration, or structural abnormalities. They can affect different parts of the brain, leading to a variety of symptoms and complications.

Some examples of brain diseases include:

1. Alzheimer's disease - a progressive degenerative disorder that affects memory and cognitive function.
2. Parkinson's disease - a movement disorder characterized by tremors, stiffness, and difficulty with coordination and balance.
3. Multiple sclerosis - a chronic autoimmune disease that affects the nervous system and can cause a range of symptoms such as vision loss, muscle weakness, and cognitive impairment.
4. Epilepsy - a neurological disorder characterized by recurrent seizures.
5. Brain tumors - abnormal growths in the brain that can be benign or malignant.
6. Stroke - a sudden interruption of blood flow to the brain, which can cause paralysis, speech difficulties, and other neurological symptoms.
7. Meningitis - an infection of the membranes surrounding the brain and spinal cord.
8. Encephalitis - an inflammation of the brain that can be caused by viruses, bacteria, or autoimmune disorders.
9. Huntington's disease - a genetic disorder that affects muscle coordination, cognitive function, and mental health.
10. Migraine - a neurological condition characterized by severe headaches, often accompanied by nausea, vomiting, and sensitivity to light and sound.

Brain diseases can range from mild to severe and may be treatable or incurable. They can affect people of all ages and backgrounds, and early diagnosis and treatment are essential for improving outcomes and quality of life.

... is a disease caused by this fungus. If given the opportunity, this disease can spread to the brain and cause ... Phaeohyphomycosis is an uncommon infection, but the number of cases reported has been increasing in recent years. Fungal ... Conclusively, phaeohyphomycosis is a highly prolific disease that is caused by multiple genera of fungi. The disease is ... Case of phaeohyphomycosis producing sporotrichoid lesions. Journal of Dermatology 40:638-640. Cai, Q., G. Lv, Y. Jiang, H. Mei ...
Phaeohyphomycosis - Infectious Diseases. Merck Manuals Professional Edition. Ahmed, S. A.; Khan, Z.; Wang, X.; Moussa, T. A. A ... There have been at least two reported cases of cerebral phaeohyphomycosis in humans with one case resulting in death, reported ... Chhonkar, A.; Kataria, D.; Tambe, S.; Nayak, C. S. (2016). "Three rare cases of cutaneous phaeohyphomycosis". Indian Journal of ... a New Agent of Cerebral Phaeohyphomycosis". Journal of Clinical Microbiology. 41 (11): 5302-5307. doi:10.1128/JCM.41.11.5302- ...
Acremonium List of cutaneous conditions Naggie S, Perfect JR (June 2009). "Molds: hyalohyphomycosis, phaeohyphomycosis, and ... and may be contrasted with phaeohyphomycosis.: 329 A hyalohyphomycetes example is Fusarium. ...
It can occasionally cause pulmonary and cutaneous phaeohyphomycosis and it has been isolated from cerebrospinal fluid in an ... Castro, A. S.; Oliveira, A.; Lopes, V. (31 May 2013). "Pulmonary phaeohyphomycosis: a challenge to the clinician". European ... Annessi, G.; Cimitan, A.; Zambruno, G.; Silverio, A. Di (24 April 1992). "Cutaneous phaeohyphomycosis due to Cladosporium ... "Developments in hyalohyphomycosis and phaeohyphomycosis". Medical Mycology. 32 (s1): 329-349. doi:10.1080/02681219480000951. ...
The fungus has been known to cause cutaneous and subcutaneous phaeohyphomycosis, and as a lung colonist in people with cystic ... The fatality rate for such infections is reported to be over 90%. Central nervous system phaeohyphomycosis is rare, and for ... While over 100 fungal species can cause phaeohyphomycosis, E. dermatitidis is one of the two fungi most frequently implicated, ... As with other black yeasts that cause phaeohyphomycosis, melanin appears to have defensive purpose, and helps protect E. ...
Several genera of fungi are found to cause phaeohyphomycosis, but it is a rare case caused by C. oxysporum. In a 2006 case ... Cutaneous phaeohyphomycosis caused by Cladosporium oxysporum". Mycoses. 42 (1-2): 111-115. doi:10.1046/j.1439-0507.1999.00263.x ... It is also reported that C. oxysporum can also cause occasional cutaneous phaeohyphomycosis and invasion of the neck lymph ... It was also tested that phaeohyphomycosis occurred after implanting the fungus from the environment to exposed tissue. The ...
Romano, C; Fimiani, M; Pellegrino, M; Valenti, L; Casini, L; Miracco, C; Faggi, E (1996). "Cutaneous phaeohyphomycosis due to ...
Another case in which identified was where it caused cerebral phaeohyphomycosis but this was treated successfully and the ... "Subcutaneous phaeohyphomycosis caused by Cladosporium sphaerospermum". Mycoses. 51 (1): 070726205023006--. doi:10.1111/j.1439- ... as an allergen and mainly causes problems in patients with respiratory tract diseases as well as subcutaneous phaeohyphomycosis ...
Diagnosis of cerebral phaeohyphomycosis by R. mackenziei is confirmed by the microscopic observation of pigmented fungal ... Untreated cerebral phaeohyphomycosis caused by Rhinocladiella mackenziei has a mortality rate of nearly 100%, although some ... Campbell, C.K.; Al-Hedaithy, S.S.A. (1993). "Phaeohyphomycosis of the brain caused by Ramichloridium mackenziei sp. nov. in ... ISBN 978-1-4443-3070-0. Li, Dong Ming; De Hoog, G Sybren (2009). "Cerebral phaeohyphomycosis-a cure at what lengths?". The ...
Doctor Fungus Ben-Ami R, Lewis RE, Raad II, Kontoyiannis DP (April 2009). "Phaeohyphomycosis in a tertiary care cancer center ...
However, there are a few cases of apparently healthy patients who developed phaeohyphomycosis. One such case involved a 55-year ... Ajello, L.; Iger, M.; Wybel, R.; Vigil, F. J. (November 1980). "Drechslera rostrata as an Agent of Phaeohyphomycosis". ... Saint-Jean, Maud; St-Germain, Guy; Laferrière, Celine; Tapiero, Bruce (May 2007). "Hospital- acquired phaeohyphomycosis due to ... McGinnis, Michael; Rinaldi, Michael; Winn, Richard (August 1986). "Emerging Agents of Phaeohyphomycosis: Pathogenic Species of ...
Revankar SG, Patterson JE, Sutton DA, Pullen R, Rinaldi MG (February 2002). "Disseminated phaeohyphomycosis: review of an ... A 2002 review of 72 cases of disseminated phaeohyphomycosis reported poor outcomes for the antifungal treatment using ...
Agrawal, Abha; Singh, S. M. (July 1995). "Two cases of cutaneous phaeohyphomycosis caused by". Mycoses. 38 (7-8): 301-303. doi: ...
Previous cases of black grain mycetoma caused by E. jeanselmei were clinically treated and cases of phaeohyphomycosis caused by ... Maeda, H; Shibuya, H; Yamaguchi, Y; Miyoshi, T; Irie, M; Sato, T (December 2008). "Feline digital phaeohyphomycosis due to ... There have been several cases of E. jeanselmei being the etiological agent of phaeohyphomycosis in domesticated cats where ... CHUAN, MING-TUO; WU, MIN-CHEE (1995). "Subcutaneous Phaeohyphomycosis Caused by Exophiala Jeanselmei: Successful Treatment with ...
Osiyemi, OO; Dowdy, LM; Mallon, SM; Cleary, T (2001). "Cerebral phaeohyphomycosis due to a novel species: report of a case and ... Padhye, AA; Dunkel, JD; Winn, RM; Weber, S; Ewing, EP; de Hoog, GS (1999). "Subcutaneous phaeohyphomycosis caused by an ... arxii was assumed to be the cause of subcutaneous phaeohyphomycosis of an ulcer in a 68-year-old woman, however, these results ... arxii was responsible for causing both cerebral and lung phaeohyphomycosis in a 30-year-old African women following a heart ...
McGinnis, Michael R. (1983). "Chromoblastomycosis and phaeohyphomycosis: New concepts, diagnosis, and mycology". Journal of the ...
... bantiana causes the rare brain disease cerebral phaeohyphomycosis. Cladophialophora carrionii is a common ...
1989). "Cerebral Phaeohyphomycosis Caused by Chaetomium globosum in a Renal Transplant Recipient". J Clin Microbiol 27(10): ... C. globosum can induce petechia and skin lesions, as well as phaeohyphomycosis and brain abscess. The latter diseases are very ... "Implantation phaeohyphomycosis caused by a non-sporulating Chaetomium species ". Journal de Mycologie Medicale 24(2): 161-165. ...
This type of phaeohyphomycosis is associated with a high morbidity and mortality rate. To treat patients with this type of ... Phialemonium curvatum has been known to peritonitis, which is a phaeohyphomycosis affecting the peritoneal cavity, and is ... "Pulmonary Phialemonium curvatum phaeohyphomycosis in a Standard Poodle dog". Medical Mycology. 46 (4): 355-9. doi:10.1080/ ...
Lin, Yuanzhu; Li, Xiangyin (1995). "First Case of Phaeohyphomycosis Caused by Chaetomium Murorum in China". Chinese Journal of ... The infection can cause subcutaneous phaeohyphomycosis mostly in people with compromised immune systems. Symptoms include ...
"Subcutaneous phaeohyphomycosis caused by Wallemia sebi in an immunocompetent host". Journal of Clinical Microbiology. 46 (3): ...
In a review of 101 cases of phaeohyphomycosis by Revankar et al., C. bantiana was the causal agent responsible for 48% of cases ... It is one of the most common causes of systemic phaeohyphomycosis in mammals. Cladophialophora bantiana is a member of the ... It has been known to cause systemic phaeohyphomycosis in both cats and dogs. Cladophialophora bantiana is known to cause a ... Since infection is very rare, there is no standard therapy for treatment of C. bantiana phaeohyphomycosis, however combination ...
Guarro J, Gugnani HC, Sood N, Batra R, Mayayo E, Gene J, Kakkar S. (2008). "Subcutaneous phaeohyphomycosis caused by Wallemia ...
Summerbell, RC; Krajden, S; Levine, R; Fuksa, M (2004). "Subcutaneous phaeohyphomycosis caused by Lasiodiplodia theobromae and ...
Cerebral phaeohyphomycosis due to Thielavia subthermophila is characterized by the production of pus and necrotic tissue in the ... Symptoms of cerebral phaeohyphomycosis include foaming at the mouth, fever, seizures, involuntary urination, and uncontrolled ... "Fatal cerebral phaeohyphomycosis in an immunocompetent individual due to Thielavia subthermophila". Journal of Clinical ... and immune enhancement can be used to treat cerebral phaeohyphomycosis by Thielavia subthermophila, although despite treatment ...
... is one of the main causative agents of phaeohyphomycosis. Initial infection via breaks to the epidermal ... though the specific best regimen depends on the nature and location of the phaeohyphomycosis. When treating immunocompromised ...
The juveniles have been found to have phaeohyphomycosis caused by infection with fungi of the genus Devriesia, the first case ... Melanie J. Peel; Lance Adams; Brittany Stevens; Michael M. Garner; Cheryl Maguire (2021). "Systemic phaeohyphomycosis in ...
Padhye AA, Ajello L, Wieden MA, Steinbronn KK (1986). "Phaeohyphomycosis of the nasal sinuses caused by a new species of ... This genus is among three dematiaceous that are categorized for containing pathogens leading to diseases like phaeohyphomycosis ...
It can also cause systemic disseminated phaeohyphomycosis affecting other organs including the lungs. Infections due to this ... a New Agent of Cerebral Phaeohyphomycosis". Journal of Clinical Microbiology. 41 (11): 5302-5307. doi:10.1128/jcm.41.11.5302- ...
Prior to 1986, O. gallopava was known as an agent of phaeohyphomycosis and fatal encephalitis mainly in poultry. Even though ... This method is useful to remove lesions formed in the affected organ due to phaeohyphomycosis. Surgical resection is especially ... Like other melanized fungi, the clinical presentation of O. gallopava is phaeohyphomycosis characterized by darkly colored ... Kralovic, SM; Rhodes, JC (September 1995). "Phaeohyphomycosis caused by Dactylaria (human dactylariosis): report of a case with ...
Phaeohyphomycosis is a disease caused by this fungus. If given the opportunity, this disease can spread to the brain and cause ... Phaeohyphomycosis is an uncommon infection, but the number of cases reported has been increasing in recent years. Fungal ... Conclusively, phaeohyphomycosis is a highly prolific disease that is caused by multiple genera of fungi. The disease is ... Case of phaeohyphomycosis producing sporotrichoid lesions. Journal of Dermatology 40:638-640. Cai, Q., G. Lv, Y. Jiang, H. Mei ...
Deep dermal/subcuticular phaeohyphomycosis, dog. Note the pigmented fungal hyphae. H&E stain. ...
... Phaeohyphomycosis Pleosporales Research Letter ... We identified P. percutanea from a patient with subcutaneous phaeohyphomycosis. From our culture collection, we identified the ... "Parathyridaria percutanea and Subcutaneous Phaeohyphomycosis" vol. 25, no. 9, 2019. Export RIS Citation Information.. ... "Parathyridaria percutanea and Subcutaneous Phaeohyphomycosis" 25, no. 9 (2019). Rudramurthy, Shivaprakash M. et al. " ...
Phaeohyphomycosis - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the MSD Manuals - Medical ... Phaeohyphomycosis can be caused by many species of dark, melanin-pigmented dematiaceous fungi including Bipolaris, ... Phaeohyphomycosis refers to infections caused by many kinds of dark, melanin-pigmented dematiaceous fungi. It is distinguished ... Phaeohyphomycosis is distinguished from chromoblastomycosis and mycetoma by the absence of specific histopathologic findings ...
Phaeohyphomycosis Traumatic implantation of dark fungi into subcutaneous tissue • Variety of infections but nodules/lesions ... Exophiala species Black Molds cause Mycetoma/Chromomycosis/Phaeohyphomycosis plus sinusitis, pulmonary, brain, and disseminated ...
Exophiala spinifera as a cause of cutaneous phaeohyphomycosis: case study and review of the literature Tuesday, December 23, ... Histologic appearance occurs in one of two patterns--phaeohyphomycosis or chromoblastomycosis. While E. spinifera appears to be ...
We describe fatal phaeohyphomycosis due to Veronaea botryosa in captive Whites tree frogs (Litoria caerulea), the first ... clinicopathologic features of a rare cause of phaeohyphomycosis in captive Whites tree frogs (Litoria caerulea) ...
Cerebral phaeohyphomycosis caused by Exophiala lecanii-corni. Fan Y, Chen S, Li S, Wang Y, Li L, Xiao B, Li J, Long L. Fan Y, ...
Cardiothoracic surgical site phaeohyphomycosis caused by Bipolaris mould, multiple US states, 2008-2013: a clinical description ... Rhinocladiella mackenziei as an emerging cause of cerebral phaeohyphomycosis in Pakistan: a case series. Clin Infect Dis 2011; ... Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET). ... A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases. Open Forum ...
Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J Am Acad Dermatol. 1983 Jan. 8(1):1-16. [ ... With the introduction of the concept of phaeohyphomycosis by McGinnis in 1983, [4] differentiation among these diseases became ... From phaeohyphomycosis to disseminated chromoblastomycosis: A retrospective study of infections caused by dematiaceous fungi. ... Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment. ...
Nixon D, Greene J, Sandin R, Fenske N, Glass L. Empirical treatment of subcutaneous phaeohyphomycosis with itraconazole. Infect ... Nixon D, Greene J, Sandin R, Fenske N, Glass L. Empirical treatment of subcutaneous phaeohyphomycosis with itraconazole. Infect ...
Ajello, L., Hyalohyphomycosis and phaeohyphomycosis: two global disease entities of public health importance. Eur. J. Epidemiol ...
Simultaneous Coccidioidomycosis and Phaeohyphomycosis in a Kidney Transplant Recipient: A Case Report and Literature Review. ... present a case of simultaneous vertebral infection caused by Coccidioides immitis-posadasii and subcutaneous phaeohyphomycosis ...
Phaeohyphomycosis Due to Exophiala jeanselmei: An Emerging Pathogen in India--Case Report and Review. Bhardwaj S, Capoor MR, ...
Subcutaneous Phaeohyphomycosis in a Renal Transplant Recipient Successfully Treated with Voriconazole. Christian Grønhøj Larsen ...
Aetiology and histopathology of a systemic phaeohyphomycosis in farmed lumpfish, Cyclopterus lumpus. K. E. Johnson, M. A. ...
Cerebral phaeohyphomycosis brought on by CladoYau Y C, de Nanassy J, Summerbell R C, Matlow A G, Richardson phialophora ...
One patient with phaeohyphomycosis-related sinusitis and one patient with sinusitis caused by Fusarium and Penicillium ...
Subcutaneous phaeohyphomycosis: A rare case. Ahmad, Z., Indramaya, D. M., Widia, Y., Anggraeni, S., Astari, L., Ervianti, E. & ...
A case of Phaeohyphomycosis caused by Corynespora cassiicola infection. BMC Infect Dis. 2018;18(1):444. ... and subcutaneous phaeohyphomycosis [4]. Therefore, the pathogenic mechanism of C. cassiicola against plants should be well ...
Implantation subcutaneous phaeohyphomycosis caused by Rhytidhysteron rufulum: A case report. Dingle, Tanis C; Jansen, Bradley; ...
... phaeohyphomycosis, macrorhabdiosis, sarcocystosis and proventricular spirurids. ...
Invasive mycotic infections caused by Chaetomium perlucidum, a new agent of cerebral phaeohyphomycosis. J Clin Microbiol. 2003 ...
Ringworm in pets may often be asymptomatic, resulting in a carrier condition which infects other pets. In some cases, the disease only appears when the animal develops an immunodeficiency condition. Circular bare patches on the skin suggest the diagnosis, but no lesion is truly specific to the fungus. Similar patches may result from allergies, sarcoptic mange, and other conditions. Three species of fungi cause 95% of dermatophytosis in pets:[citation needed] these are Microsporum canis, Microsporum gypseum, and Trichophyton mentagrophytes. Veterinarians have several tests to identify ringworm infection and identify the fungal species that cause it: Woods test: This is an ultraviolet light with a magnifying lens. Only 50% of M. canis will show up as an apple-green fluorescence on hair shafts, under the UV light. The other fungi do not show. The fluorescent material is not the fungus itself (which does not fluoresce), but rather an excretory product of the fungus which sticks to hairs. Infected ...
Phaeohyphomycosis, Cutaneous. Phaeohyphomycosis, Subcutaneous. Subcutaneous Phaeohyphomycoses. Subcutaneous Phaeohyphomycosis. ... Subcutaneous Phaeohyphomycosis Entry term(s). Phaeohyphomycoses, Subcutaneous Phaeohyphomycosis, Subcutaneous Subcutaneous ... Cutaneous Phaeohyphomycosis Entry term(s). Cutaneous Phaeohyphomycoses Phaeohyphomycoses, Cutaneous Phaeohyphomycosis, ... Phaeohyphomycosis - Preferred Concept UI. M0553998. Scope note. OPPORTUNISTIC INFECTIONS caused by the dematiaceous (darkly ...
Phaeohyphomycosis Whats New Last Posted: Jan 01, 2011 * Phaeohyphomycosis From NCATS Genetic and Rare Diseases Information ...
keywords = "Microsphaeropsis arundinis, Phaeohyphomycosis, Phialophora verrucosa",. author = "Webb, {Camille M.} and Lindy Ross ...
Phaeohyphomycosis. These infections can be concentrated in a specific part of your kittys body or spread throughout the entire ...
  • We identified P. percutanea from a patient phylogenetic analysis of ITS and large ribosomal subunit with subcutaneous phaeohyphomycosis. (cdc.gov)
  • We identified P. percutanea from a patient with subcutaneous phaeohyphomycosis. (cdc.gov)
  • The initial subcutaneous cyst from the infection can become systemic and spread rapidly to renal, pulmonary and cerebral systems (see CEREBRAL PHAEOHYPHOMYCOSIS) in an IMMUNOCOMPROMISED HOST. (bvsalud.org)
  • The genus Alternaria is one of the most common black moulds and appears to be increasing as a causative agent of subcutaneous phaeohyphomycosis, particularly among immunosuppressed patients. (unl.pt)
  • Phaeohyphomycosis is a diverse group of fungal infections, caused by dematiaceous fungi whose morphologic characteristics in tissue include hyphae, yeast-like cells, or a combination of these. (wikipedia.org)
  • Phaeohyphomycosis, a fungal infection, is one type of foot lump that can occur in people with diabetes. (kybun.us)
  • El quiste subcutáneo inicial de la infección puede llegar a ser sistémico y extenderse rápidamente hacia los sistemas renales, pulmonares y cerebrales (ver FEOHIFOMICOSIS CEREBRAL) en un HUESPED INMUNOCOMPROMETIDO. (bvsalud.org)
  • Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei (formerly Ramichloridium mackenziei): a taxonomic update and review of the literature. (atlasclinicalfungi.org)
  • Cerebral phaeohyphomycosis: Importance of early diagnosis and management. (ina-jns.org)
  • Genomic Analyses of Cladophialophora bantiana , a Major Cause of Cerebral Phaeohyphomycosis Provides Insight into Its Lifestyle, Virulence and Adaption in Host. (codongenomics.com)
  • Sporotrichosis was the most prevalent mycosis (19/54), followed by dermatophytosis (9/54), cryptococcosis (8/54), candidiasis (7/54), and phaeohyphomycosis (4/54). (bvsalud.org)
  • Phaeohyphomycosis is distinguished from chromoblastomycosis and mycetoma by the absence of specific histopathologic findings such as sclerotic bodies or grains in tissue. (msdmanuals.com)
  • The infection should not be confused with mycoses, such as mycetoma or phaeohyphomycosis, caused by other dematiaceous fungi. (medscape.com)
  • The term "phaeohyphomycosis" was introduced to determine infections caused by dematiaceous (pigmented) filamentous fungi which contain melanin in their cell walls. (wikipedia.org)
  • Phaeohyphomycosis refers to infections caused by many kinds of dark, melanin-pigmented dematiaceous fungi. (msdmanuals.com)
  • Phaeohyphomycosis Due to Exophiala jeanselmei: An Emerging Pathogen in India--Case Report and Review. (nih.gov)
  • Phaeohyphomycosis caused by Alternaria infectoria presenting as multiple vegetating lesions in a renal transplant patient. (unl.pt)
  • Central nervous system phaeohyphomycosis caused by Cladophialophora bantiana in an immunocompetent host. (birchtreemed.com)
  • Ajello, L., Hyalohyphomycosis and phaeohyphomycosis: two global disease entities of public health importance. (mold-help.org)
  • Phaeohyphomycosis has been attributed to more than 100 species and 60 genera of fungi over the past several decades. (wikipedia.org)
  • From birds to equines, Phaeohyphomycosis persists and has a massive range of clinical signs throughout differing species. (wikipedia.org)
  • treatment of phaeohyphomycosis depends on the clinical syndrome and status of the patient. (msdmanuals.com)
  • Phaeohyphomycosis is an uncommon infection, but the number of cases reported has been increasing in recent years. (wikipedia.org)
  • We identified P. percutanea from a patient phylogenetic analysis of ITS and large ribosomal subunit with subcutaneous phaeohyphomycosis. (cdc.gov)
  • Primary subcutaneous phaeohyphomycosis can rarely be caused by Cladophialophora bantiana, and we present the histologic and culture findings of such a case. (nih.gov)
  • Our case highlights the role of trauma and immunosuppression in the pathogenesis of subcutaneous phaeohyphomycosis. (nih.gov)
  • 2. Subcutaneous phaeohyphomycosis in kidney transplant recipients: A series of seven cases. (nih.gov)
  • 12. Subcutaneous Phaeohyphomycosis Caused By Pyrenochaeta Romeroi in a Kidney Transplant Recipient: A Case Report. (nih.gov)
  • Alternaria alternata is a causative agent of subcutaneous phaeohyphomycosis and mycotic keratitis. (stemcelldaily.com)
  • Subcutaneous phaeohyphomycosis in a patient with IgG4-related sclerosing disease caused by a novel ascomycete, Hongkongmyces pedis gen. et sp. (hku.hk)
  • 5. Cutaneous phaeohyphomycosis. (nih.gov)
  • 16. Three cases of cutaneous phaeohyphomycosis by Exophiala jeanselmei. (nih.gov)
  • It is allergenic and occasionally causes systemic or cutaneous phaeohyphomycosis (Infections caused from fungi or yeasts). (indepth.energy)
  • The terms superficial, cutaneous and corneal, subcutaneous, and systemic phaeohyphomycosis are proposed for the major categories of phaeohyphomycosis. (qxmd.com)
  • The initial subcutaneous cyst from the infection can become systemic and spread rapidly to renal, pulmonary and cerebral systems (see CEREBRAL PHAEOHYPHOMYCOSIS ) in an IMMUNOCOMPROMISED HOST . (bvsalud.org)
  • ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. (fidssa.co.za)
  • Itraconazole treatment of phaeohyphomycosis. (nih.gov)
  • The patient presented with a case of cladosporiosis, or cerebral phaeohyphomycosis, caused by the dematiaceous fungal organism, Cladophialophora bantiana , formerly Cladosporium bantianum . (cdc.gov)
  • Frank T, Esquenazi, Masayuki N, Wanger A, Portnoy B, Shepard S. Disseminated phaeohyphomycosis with brain abscess and biliary invasion due to Bipolaris spp. (uth.edu)
  • INTRODUCTION AND IMPORTANCE Phaeohyphomycosis is a rare fungal infection primarily affecting immunocompromised individuals. (bvsalud.org)
  • Phaeohyphomycosis has been attributed to more than 100 species and 60 genera of fungi over the past several decades. (wikipedia.org)
  • Phaeohyphomycosis is a large category of fungal infections that are caused by organisms from the Bipolaris, Curvularia, Exserohilum, Pseudallescheria, and Scedosporium species. (healthychildren.org)
  • In contrast, phaeohyphomycosis is a collective term for a heterogeneous group of mycotic infections that contain dematiaceous yeastlike cells, pseudohyphae-like elements, hyphae, or any combination of these forms in tissue. (qxmd.com)
  • Histopathological examination and fine needle aspiration cytology (FNAC) revealed melanized hyphae , leading to a final diagnosis of phaeohyphomycosis . (bvsalud.org)
  • Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. (qxmd.com)
  • Role of cytopathology in diagnosing phaeohyphomycosis masquerading as nerve abscess in a lepromatous leprosy patient: A case report. (bvsalud.org)
  • This case highlights the unusual presentation of phaeohyphomycosis mimicking a nerve abscess in a leprosy patient . (bvsalud.org)
  • We report a case of oculopharyngeal phaeohyphomycosis of the right eye which developed in a 64-year-old Indian male. (wanoengineeringsystems.com)
  • These infections have a common name - phaeohyphomycosis [7]. (bustmold.com)
  • Anne Puel combines subjects such as Interleukin, Whole blood and Phaeohyphomycosis with her study of Medical microbiology. (research.com)